177 related articles for article (PubMed ID: 28805498)
21. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
Ways JP; Parham P
Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
[TBL] [Abstract][Full Text] [Related]
23. Greatest Hits-Innovative Technologies for High Throughput Identification of Bispecific Antibodies.
Hofmann T; Krah S; Sellmann C; Zielonka S; Doerner A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911608
[TBL] [Abstract][Full Text] [Related]
24. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
25. Fab is the most efficient format to express functional antibodies by yeast surface display.
Sivelle C; Sierocki R; Ferreira-Pinto K; Simon S; Maillere B; Nozach H
MAbs; 2018 Jul; 10(5):720-729. PubMed ID: 29708852
[TBL] [Abstract][Full Text] [Related]
26. High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.
Whiteaker JR; Zhao L; Frisch C; Ylera F; Harth S; Knappik A; Paulovich AG
J Proteome Res; 2014 Apr; 13(4):2187-96. PubMed ID: 24568200
[TBL] [Abstract][Full Text] [Related]
27. Rapid kinetic-based screening of human Fab fragments.
Steukers M; Schaus JM; van Gool R; Hoyoux A; Richalet P; Sexton DJ; Nixon AE; Vanhove M
J Immunol Methods; 2006 Mar; 310(1-2):126-35. PubMed ID: 16481004
[TBL] [Abstract][Full Text] [Related]
28. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
[TBL] [Abstract][Full Text] [Related]
29. An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatants.
Paul S; Connor J; Nesspor T; Haytko P; Boakye K; Chiu ML; Jiang H
Protein Expr Purif; 2016 May; 121():133-40. PubMed ID: 26826313
[TBL] [Abstract][Full Text] [Related]
30. Real-time biospecific interaction analysis of a natural human polyreactive monoclonal IgM antibody and its Fab and scFv fragments with several antigens.
Roggenbuck D; König H; Niemann B; Schoenherr G; Jahn S; Porstmann T
Scand J Immunol; 1994 Jul; 40(1):64-70. PubMed ID: 8029645
[TBL] [Abstract][Full Text] [Related]
31. Topical ocular treatment with monoclonal antibody Fab fragments targeting Japanese cedar pollen Cry j 1 inhibits Japanese cedar pollen-induced allergic conjunctivitis in mice.
Mizutani N; Nabe T; Yoshino S
Eur J Pharmacol; 2017 Mar; 798():105-112. PubMed ID: 28119075
[TBL] [Abstract][Full Text] [Related]
32. Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2.
Lim SA; Gramespacher JA; Pance K; Rettko NJ; Solomon P; Jin J; Lui I; Elledge SK; Liu J; Bracken CJ; Simmons G; Zhou XX; Leung KK; Wells JA
MAbs; 2021; 13(1):1893426. PubMed ID: 33666135
[TBL] [Abstract][Full Text] [Related]
33. Comparative binding of disulfide-bridged PEG-Fabs.
Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
[TBL] [Abstract][Full Text] [Related]
34. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
35. Direct Comparison of the Hinge-Cleaving Proteases IgdE and BdpK for LC-MS-Based IgG1 Clonal Profiling.
van Rijswijck DMH; Bondt A; de Kat N; Lood R; Heck AJR
Anal Chem; 2024 Jan; 96(1):23-27. PubMed ID: 38105593
[TBL] [Abstract][Full Text] [Related]
36. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system.
Hur BU; Yoon JB; Liu LK; Cha SH
Immunol Lett; 2010 Nov; 134(1):55-61. PubMed ID: 20797408
[TBL] [Abstract][Full Text] [Related]
38. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
Tustian AD; Endicott C; Adams B; Mattila J; Bak H
MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
[TBL] [Abstract][Full Text] [Related]
39. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Wagner CL; Mascelli MA; Neblock DS; Weisman HF; Coller BS; Jordan RE
Blood; 1996 Aug; 88(3):907-14. PubMed ID: 8704248
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies.
Springer TA; Bhattacharya A; Cardoza JT; Sanchez-Madrid F
Hybridoma; 1982; 1(3):257-73. PubMed ID: 6208128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
